COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 1349: Articles 13481-13490  | Next

The COVID-19 Yorkshire Rehabilitation Scale (C19-YRS): application and psychometric analysis in a post-COVID-19 syndrome cohort
Preston, N. J., Parkin, A., Makower, S., Ross, D. H., Gee, J., Halpin, S. J., Horton, M. C., O'Connor, R. J., Sivan, M.
10.1101/2021.06.28.21259613 — Posted: 2021-06-30
The Impact of COVID-19 Restrictions on Childhood Vaccination Uptake: A Rapid Review
Heneghan, C., Brassey, J., Jefferson, T.
10.1101/2021.06.25.21259371 — Posted: 2021-06-30
Comparative evaluation of the transmissibility of SARS-CoV-2 variants of concern
Wang, L., Didelot, X., Bi, Y., Gao, G. F.
10.1101/2021.06.25.21259565 — Posted: 2021-06-30
ASSESSMENT OF POTENTIAL SARS-CoV-2 VIRUS N GENE INTEGRATION INTO HUMAN GENOME REVEALS NO SIGNIFICANT IMPACT ON RT-qPCR COVID-19 DIAGNOSTIC TESTING
Briggs, E., Ward, W., Rey, S., Law, D., Nelson, K., Bois, M., Ostrov, N., Lee, H. H., Laurent, J. M., Mita, P.
10.1101/2021.06.21.21258023 — Posted: 2021-06-30
Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients: An Observational, Prospective Cohort Study Interim Analysis
Haidar, G., Agha, M., Lukanski, A., Linstrum, K., Troyan, R., Bilderback, A., Rothenberger, S., McMahon, D. K., Crandall, M., Enick, P. N., Sobolewksi, M., Collins, K., Schwartz, M. B., Dueker, J. M., Silveira, F. P., Keebler, M. E., Humar, A., Luketich, J. D., Morrell, M. R., Pilewski, J. M., McDyer, J. F., Pappu, B., Ferris, R. L., Marks, S. M., Klamar-Blain, C., Parikh, U. M., Heaps, A., Kip, P. L., Wells, A., Minnier, T., Angus, D., Mellors, J. W.
10.1101/2021.06.28.21259576 — Posted: 2021-06-30
Temporal trends in primary care-recorded self-harm during and beyond the first year of the COVID-19 pandemic: time series analysis of electronic healthcare records for 2.8 million patients in the Greater Manchester Care Record
Steeg, S., Bojanic, L., Tilston, G., Williams, R., Jenkins, D. A., Carr, M. J., Peek, N., Ashcroft, D. M., Kapur, N., Voorhees, J., Webb, R. T.
10.1101/2021.06.23.21259400 — Posted: 2021-06-30
Thrombocytopenia and splenic platelet directed immune responses after intravenous ChAdOx1 nCov-19 administration
Nicolai, L., Leunig, A., Pekayvaz, K., Anjum, A., Riedlinger, E., Eivers, L., Hoffknecht, M.-L., Rossaro, D., Escaig, R., Kaiser, R., Polewka, V., Titova, A., Spiekermann, K., Iannacone, M., Stark, K., Massberg, S.
10.1101/2021.06.29.450356 — Posted: 2021-06-29
Genetic diversity and evolution of SARS-CoV-2 in Belgium during the first wave outbreak
Wawina-Bokalanga, T., Marti-Carreras, J., Vanmechelen, B., Bloemen, M., Wollants, E., Laenen, L., Cuypers, L., Beuselinck, K., Lagrou, K., Andre, E., Van Ranst, M., Maes, P.
10.1101/2021.06.29.450330 — Posted: 2021-06-29
Absolute quantitation of individual SARS-CoV-2 RNA molecules: a new paradigm for infection dynamics and variant differences
Lee, J. Y., Wing, P. A., Gala, D. S., Jarvelin, A. I., Titlow, J., Noerenberg, M., Zhuang, X., Johnson, N., Iselin, L., Thompson, M. K., Parton, R. M., Wainman, A., Agranoff, D., James, W., Castello, A., McKeating, J. A., Davis, I.
10.1101/2021.06.29.450133 — Posted: 2021-06-29
Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage
Shiliaev, N., Lukash, T., Palchevska, O., Crossman, D. K., Green, T. J., Crowley, M., Frolova, E. I., Frolov, I.
10.1101/2021.06.28.450274 — Posted: 2021-06-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).